Glipizide Tablet
Product Images NDC 52817-385

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 52817-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide Tablets 2.5mg (NDC 72888-115-01)

Label for Glipizide tablets USP 2.5 mg, oral dosage form, in a package of 100 tablets. The label shows that the product is distributed by TruPharma, LLC and manufactured by Rubicon Research Private Limited. Storage instructions specify 20° to 25°C with permissible excursions. The label also includes child-resistant closure and medication safety warnings.*

FDA Label Image

Glipizide Tablets 2.5mg (NDC 72888-115-05)

Label for GlipiZIDE Tablets USP 2.5 mg oral tablets, distributed by TruPharma LLC, packaging 500 tablets. Manufactured by Rubicon Research Private Limited, India. Includes storage instructions, Rx only designation, and child resistant container warning. The label shows the NDC 52817-385-50 and features the TruPharma logo.*

FDA Label Image

Chemical Structure (Glipizide Tabs Usp Structure)

Chemical structure diagram of glipizide, showing its molecular framework with labeled rings and functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.